StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc.

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.33−0.35 (-0.21%)

Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%

Gilead Sciences Deferred compensation plan rabbi trust assets by Quarter

Deferred compensation plan rabbi trust assets & liabilities ($M) ($M)

QuarterlyAnnual

Gilead Sciences Deferred compensation plan rabbi trust assets: $458M in Q2 2026, up 22.5% from a year earlier. That is the highest of the 38 quarters on record here.

Latest, Q2 2026
458
Period ended Jun 30, 2026
Change on a year earlier
+22.5%
374 in Q2 2025
History
38 quarters
Since Q4 2014
Sources
37
Documents cited below

Where the Q2 2026 figure comes from

“|| Deferred compensation plan | 458 | — | — | 458 | 406 | — | — | 406”

Source: Form 10-Q (gild-20260630.htm, filed 2026-08-06) ↗

Reported in Form 10-Q / 10-K Note 3 Fair Value & Note 13 Employee Benefit Plans.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedDeferred compensation plan rabbi trust assets & liabilities ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026458+22.5%Form 10-Q (gild-20260630.htm, filed 2026-08-06) ↗
Q1 2026Mar 31, 2026405+19.1%Form 10-Q (gild-20260331.htm, filed 2026-05-07) ↗
Q4 2025Dec 31, 2025406+18.4%Form 10-Q (gild-20260630.htm, filed 2026-08-06) ↗
Q3 2025Sep 30, 2025401+16.9%Form 10-Q (gild-20250930.htm, filed 2025-11-07) ↗
Q2 2025Jun 30, 2025374+14.4%Form 10-Q (gild-20250630.htm, filed 2025-08-07) ↗
Q1 2025Mar 31, 2025340+6.9%Form 10-Q (gild-20250331.htm, filed 2025-05-07) ↗
Q4 2024Dec 31, 2024343+20.8%Form 10-K (gild-20251231.htm, filed 2026-02-24) ↗
Q3 2024Sep 30, 2024343+32.4%Form 10-Q (gild-20240930.htm, filed 2024-11-12) ↗
Q2 2024Jun 30, 2024327+22.0%Form 10-Q (gild-20240630.htm, filed 2024-08-08) ↗
Q1 2024Mar 31, 2024318+27.7%Form 10-Q (gild-20240331.htm, filed 2024-05-08) ↗
Q4 2023Dec 31, 2023284+29.1%Form 10-K (gild-20241231.htm, filed 2025-02-28) ↗
Q3 2023Sep 30, 2023259+24.5%Form 10-Q (gild-20230930.htm, filed 2023-11-07) ↗
Q2 2023Jun 30, 2023268+24.7%Form 10-Q (gild-20230630.htm, filed 2023-08-04) ↗
Q1 2023Mar 31, 2023249-1.6%Form 10-Q (gild-20230331.htm, filed 2023-05-03) ↗
Q4 2022Dec 31, 2022220-15.7%Form 10-K (gild-20231231.htm, filed 2024-02-23) ↗
Q3 2022Sep 30, 2022208-16.5%Form 10-Q (gild-20220930.htm, filed 2022-11-02) ↗

Cite this data

StockData. (2026). Gilead Sciences Deferred compensation plan rabbi trust assets ($M), quarterly Q4 2014–Q2 2026 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/benefit-def-comp

See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.